Inosine monophosphate dehydrogenase (IMPDH) as a target in drug discovery

Med Res Rev. 2008 Mar;28(2):219-32. doi: 10.1002/med.20104.

Abstract

Inosine monophosphate dehydrogenase (IMPDH) is a key enzyme of de novo purine nucleotide biosynthesis and is viewed as an important target in the quest for discovery of drugs in the antiviral, antibacterial and anticancer therapeutic areas. This review focuses on the medicinal chemistry, drug discovery and chemical biology of IMPDH. Examples of IMP and cofactor site-directed inhibitors, allosteric inhibitors and isoform-selective inhibitors are presented. Comparison of IMPDHs from different organisms is also made to facilitate the design of species-selective IMPDH inhibitors for drug discovery. Special emphasis in the review is placed on IMPDH from Mycobacterium tuberculosis.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Allosteric Site / drug effects
  • Amino Acid Sequence
  • Binding Sites / drug effects
  • Drug Design
  • Humans
  • IMP Dehydrogenase / antagonists & inhibitors*
  • IMP Dehydrogenase / metabolism
  • Isoenzymes / antagonists & inhibitors
  • Ligands
  • Models, Molecular
  • Molecular Sequence Data
  • Mycobacterium tuberculosis / enzymology
  • NAD / metabolism
  • Sequence Alignment

Substances

  • Isoenzymes
  • Ligands
  • NAD
  • IMP Dehydrogenase